OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2023
(2)
2025
(1)
2024
(1)
2021
(1)
2018
(1)
2014
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study.
Not available
S-EPMC11605501
|
biostudies-literature
Cite
Impact of a self-care education programme on patients with type 2 diabetes in primary care in the Basque Country.
Not available
S-EPMC3680082
|
biostudies-literature
Cite
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.
Not available
S-EPMC9789885
|
biostudies-literature
Cite
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model.
Not available
S-EPMC8280376
|
biostudies-literature
Cite
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.
Not available
S-EPMC7095489
|
biostudies-literature
Cite
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome.
Not available
S-EPMC4122779
|
biostudies-literature
Cite
Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.
Not available
S-EPMC9862219
|
biostudies-literature
Cite
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Not available
S-EPMC11882944
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets